Compass Therapeutics Inc. (CMPX)
NASDAQ: CMPX
· Real-Time Price · USD
3.70
0.23 (6.63%)
At close: Oct 03, 2025, 3:59 PM
3.67
-0.81%
After-hours: Oct 03, 2025, 06:55 PM EDT
6.63% (1D)
| Bid | 3.45 |
| Market Cap | 511.66M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -62.03M |
| EPS (ttm) | -0.45 |
| PE Ratio (ttm) | -8.22 |
| Forward PE | -6.09 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.79 |
| Volume | 1,552,436 |
| Avg. Volume (20D) | 1,236,377 |
| Open | 3.47 |
| Previous Close | 3.47 |
| Day's Range | 3.46 - 3.71 |
| 52-Week Range | 1.27 - 4.08 |
| Beta | 1.30 |
| Ex-Dividend Date | n/a |
About CMPX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-5.09%
Compass Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
6 months ago
+17.89%
Compass Therapeutics shares are trading higher after the company announced updates and top-line data for COMPANION-002.
1 month ago · seekingalpha.com
Compass Therapeutics: Finding Their Way With More Positive Updates In BTCCompass Therapeutics' pipeline shows promise, especially with tovecimig's positive phase 2 results in biliary tract cancers and upcoming basket study plans. CTX-8371's early signals in NSCLC and TNBC ...